Objective: to determine the prothrombin time and activated partial thromboplatin time among type 2 none insulin dependent Diabetes Mellitus Patients.Materials and methods Descriptive, prospective analytical case-control based study conducted in Abdelrahamn Elsedari Hospital, Sakaka city, Aljouf Region, Saudia Arabia during the period of March to July 2009. Fifty patients and ten normal controls were studied. Patients were those who fulfilled the clinical diagnosis of type II none insulin dependent Diabetes Mellitus of either sex in all age groups, on or off treatment. The controls were normal, non- Diabetes Mellitus individuals of either sex.ResultsThe results Show that the mean level of prothrombin time type 2 diabetic patients was 12.0 Se...
Objective: The aim of this study was to find the association of postprandial blood glucose with hype...
Diabetes mellitus is associated with disturbances in haemostasis that could contribute to the develo...
Type 2 diabetes mellitus (DM2) is a metabolic disorder characterized by relative insulin deficiency,...
Diabetes mellitus contributes for initiation and progression of micro vascular and macro vascular co...
Diabetes mellitus is a heterogeneous disorder that affects cellular metabolism in variety of ways, a...
Diabetes mellitus is a common disease and it is a major cause of morbidity; several studies indicate...
Introduction: Type 2 diabetes mellitus, characterized by insulin resistance, corresponds to approxim...
Diabetes mellitus is a common disease in Sudan, and it is a major cause of morbidity, several studie...
Background: Persistent hyperglycaemia in diabetes mellitus causes coagulopathies due to glycation of...
Impact of gestational diabetes mellitus (GDM) on the coagulation system still remains unclear and th...
Diabetes mellitus can perturb normal hemostatic functions which include platelets, coagulation/antic...
Objective: The present study was designed to find out HbA1 levels and coagulation profile parameters...
PhD ThesisEvaluation of platelet dependent thrombosis and the role of dual antiplatelet therapy on b...
Full list of author information is available at the end of the articleBackground Patients with diabe...
Abstract. Diabetes mellitus is associated with disturbances in haemostasis that could contribute to ...
Objective: The aim of this study was to find the association of postprandial blood glucose with hype...
Diabetes mellitus is associated with disturbances in haemostasis that could contribute to the develo...
Type 2 diabetes mellitus (DM2) is a metabolic disorder characterized by relative insulin deficiency,...
Diabetes mellitus contributes for initiation and progression of micro vascular and macro vascular co...
Diabetes mellitus is a heterogeneous disorder that affects cellular metabolism in variety of ways, a...
Diabetes mellitus is a common disease and it is a major cause of morbidity; several studies indicate...
Introduction: Type 2 diabetes mellitus, characterized by insulin resistance, corresponds to approxim...
Diabetes mellitus is a common disease in Sudan, and it is a major cause of morbidity, several studie...
Background: Persistent hyperglycaemia in diabetes mellitus causes coagulopathies due to glycation of...
Impact of gestational diabetes mellitus (GDM) on the coagulation system still remains unclear and th...
Diabetes mellitus can perturb normal hemostatic functions which include platelets, coagulation/antic...
Objective: The present study was designed to find out HbA1 levels and coagulation profile parameters...
PhD ThesisEvaluation of platelet dependent thrombosis and the role of dual antiplatelet therapy on b...
Full list of author information is available at the end of the articleBackground Patients with diabe...
Abstract. Diabetes mellitus is associated with disturbances in haemostasis that could contribute to ...
Objective: The aim of this study was to find the association of postprandial blood glucose with hype...
Diabetes mellitus is associated with disturbances in haemostasis that could contribute to the develo...
Type 2 diabetes mellitus (DM2) is a metabolic disorder characterized by relative insulin deficiency,...